DICE
Income statement / Annual
Last year (2022), DICE Therapeutics, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2022, DICE Therapeutics, Inc.'s net income was -$81.66 M.
See DICE Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$1.13 M
|
$863,000.00
|
$5.78 M
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$1.13 M |
$863,000.00 |
$5.78 M |
| Gross Profit Ratio |
0 |
1 |
1 |
1 |
| Research and Development
Expenses |
$62.56 M
|
$36.51 M
|
$19.58 M
|
$15.72 M
|
| General & Administrative
Expenses |
$25.66 M
|
$12.22 M
|
$5.00 M
|
$3.61 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$25.66 M
|
$12.22 M
|
$5.00 M
|
$3.61 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$88.22 M |
$48.73 M |
$24.58 M |
$19.32 M |
| Cost And Expenses |
$88.22 M |
$48.73 M |
$24.58 M |
$19.32 M |
| Interest Income |
$5.21 M |
$136,000.00 |
$139,000.00 |
$635,000.00 |
| Interest Expense |
$679,000.00 |
$174,000.00 |
$13,000.00 |
$26,000.00 |
| Depreciation &
Amortization |
$5.21 M
|
$136,000.00
|
$836,000.00
|
$1.34 M
|
| EBITDA |
-$83.01 M
|
-$47.47 M
|
-$22.89 M
|
-$12.21 M
|
| EBITDA Ratio |
0 |
-42.19 |
-26.52 |
-2.11 |
| Operating Income Ratio
|
0
|
-42.31
|
-27.49
|
-2.35
|
| Total Other
Income/Expenses Net |
$4.33 M
|
-$1.36 M
|
-$18,000.00
|
$609,000.00
|
| Income Before Tax |
-$83.89 M |
-$48.96 M |
-$23.74 M |
-$12.94 M |
| Income Before Tax Ratio
|
0
|
-43.52
|
-27.51
|
-2.24
|
| Income Tax Expense |
-$2.22 M |
-$487,000.00 |
$13,000.00 |
$26,000.00 |
| Net Income |
-$81.66 M |
-$48.47 M |
-$23.75 M |
-$12.96 M |
| Net Income Ratio |
0 |
-43.09 |
-27.52 |
-2.24 |
| EPS |
-2.07 |
-3.91 |
-1.02 |
-0.56 |
| EPS Diluted |
-2.07 |
-3.91 |
-1.02 |
-0.56 |
| Weighted Average Shares
Out |
$39.40 M
|
$12.38 M
|
$23.23 M
|
$23.23 M
|
| Weighted Average Shares
Out Diluted |
$39.40 M
|
$12.38 M
|
$23.23 M
|
$23.23 M
|
| Link |
|
|
|
|
